BackRecce Pharmaceuticals Overview

Recce Pharmaceuticals Profit Margin

Latest profit margin for Recce Pharmaceuticals: -484.43% — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

Quarterly Profit Margin

N/A

As of Jun 2026

Annual Profit Margin (TTM)

-484.43%
↓ 48.04% YoY

Trailing 12 months ending Jun 2026

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading

Recce Pharmaceuticals (RECEF) FAQ

The latest profit margin for RECEF is -484.43% as of June 2026. That compares with -327.24% in the prior-year period — down 48.0% year over year. That is below the Healthcare sector average of 17.63%. Investors often review this figure alongside Recce Pharmaceuticals's historical trend and sector peers before judging valuation or financial health.

Over the past year, RECEF's profit margin moved from -327.24% to -484.43% — a 48.0% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Recce Pharmaceuticals's valuation or profitability profile.

Against Healthcare companies, RECEF currently prints -484.43% for profit margin, while the sector average sits near 17.63%. That is roughly 2848.0% below the sector mean. Large gaps often invite a closer look at Recce Pharmaceuticals's growth, margins, and balance sheet.

Profit Margin shows how effectively Recce Pharmaceuticals converts resources into returns. At -484.43%, RECEF may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -327.24% in the prior-year period — down 48.0% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting RECEF's profit margin (-484.43%), review year-over-year change from -327.24%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.